首页> 外文期刊>Clinical & developmental immunology. >Comparative Approach to Define Increased Regulatory T Cells in Different Cancer Subtypes by Combined Assessment of CD127 and FOXP3
【24h】

Comparative Approach to Define Increased Regulatory T Cells in Different Cancer Subtypes by Combined Assessment of CD127 and FOXP3

机译:通过联合评估CD127和FOXP3定义不同癌症亚型中增加的调节性T细胞的比较方法

获取原文
           

摘要

In recent years an increase of functional CD4~(+)CD25~(+)regulatory T cells (T_(reg)cells) has been established for patients with solid tumors, acute leukemias, and lymphomas. We have reported an expanded pool of CD4~(+)CD25~(high)T_(reg)cells in patients with chronic lymphatic leukemia (CLL), multiple myeloma (MM) as well as its premalignant precursor monoclonal gammopathy of undetermined significance (MGUS). In healthy individuals, low-level expression of CD127 on T cells in addition to the expression of FOXP3 has been associated with T_(reg)cells. Here, we demonstrate that the expanded FOXP3~(+)T-cell population in patients with colorectal cancer, CLL, MGUS, MM, follicular lymphoma, and Hodgkin's disease are exclusively CD127~(low)T_(reg)cells and were strongly suppressive. A significant portion of CD127~(low)FOXP3~(+)T_(reg)cells expressed only low levels of CD25 suggesting that the previously reported expansion of CD25~(+)T_(reg)cells underestimates the true expansion. The assessment of CCR7 and CD45RA expression on the expanded CD4~(+)CD127~(low)FOXP3~(+)T_(reg)cells revealed an increase of both na?ve as well as central and effector memory T_(reg)cells in peripheral blood. Our data strongly support superiority of combined CD127 and FOXP3 analysis in comparison to CD25 and FOXP3 assessment for further quantification of T_(reg)cells in malignant diseases.
机译:近年来,已经为患有实体瘤,急性白血病和淋巴瘤的患者建立了功能性CD4〜(+)CD25〜(+)调节性T细胞(T_(reg)细胞)的增加。我们已经报道了在慢性淋巴白血病(CLL),多发性骨髓瘤(MM)以及其恶性前体单克隆γ病(未确定意义)的患者中,CD4〜(+)CD25〜(高)T_(reg)细胞池的扩大)。在健康个体中,除了FOXP3的表达外,T细胞上CD127的低水平表达也与T_reg细胞有关。在这里,我们证明在结直肠癌,CLL,MGUS,MM,滤泡性淋巴瘤和霍奇金病患者中,FOXP3〜(+)T细胞数量的增加仅是CD127〜(低)T_(reg)细胞,并且具有强抑制性。 CD127〜(低)FOXP3〜(+)T_(reg)细胞的很大一部分仅表达低水平的CD25,这表明先前报道的CD25〜(+)T_(reg)细胞的扩增低估了真正的扩增。在扩增的CD4〜(+)CD127〜(低)FOXP3〜(+)T_(reg)细胞上评估CCR7和CD45RA的表达揭示了幼稚以及中央和效应记忆T_(reg)细胞的增加在外周血中。与CD25和FOXP3评估相比,我们的数据强烈支持CD127和FOXP3联合分析在恶性疾病中T_(reg)细胞进一步量化方面的优越性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号